Related Experiment Video
Updated: Jul 10, 2026
07:25
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Interferon therapy for chronic hepatitis B.
Tarik Asselah1, Olivier Lada, Rami Moucari
1Service d'Hépatologie, INSERM U773, CRB3, University of Paris VII, Hôpital Beaujon, 92110 Clichy, France.
Clinics in Liver Disease
|November 6, 2007
Summary
Interferon alfa and pegylated interferon alfa, alone or with lamivudine, were evaluated for treating chronic hepatitis B. This summary covers their efficacy in managing this liver condition.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Chronic hepatitis B is a significant global health concern.
- Effective antiviral therapies are crucial for managing hepatitis B virus (HBV) infection.
- Interferon alfa has been a cornerstone therapy, with newer formulations offering potential advantages.
Purpose of the Study:
- To summarize treatment outcomes using interferon alfa and pegylated interferon alfa.
- To evaluate these agents as monotherapy and in combination with lamivudine.
- To assess their effectiveness in patients with chronic hepatitis B.
Main Methods:
- Review of clinical trial data and published studies.
- Analysis of treatment responses to interferon alfa and pegylated interferon alfa.
- Evaluation of combination therapy including lamivudine.
Main Results:
- Monotherapy with interferon alfa and pegylated interferon alfa showed variable efficacy.
- Combination therapy with lamivudine demonstrated potential for improved outcomes.
- Specific response rates and sustained viral suppression were observed.
Conclusions:
- Interferon alfa and its pegylated form offer treatment options for chronic hepatitis B.
- Combination therapy may enhance viral clearance and long-term disease control.
- Further research may refine treatment strategies for hepatitis B.
More Related Videos
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment: